CASI Pharmaceuticals, Inc. (CASI) Social Stream
CASI PHARMACEUTICALS INC (CASI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CASI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-13 | 3 | $6 | $3.5 | $4.26 | $6.15 | -30.73% |
| 2021-11-15 | 4 | $6 | $3.5 | $4.26 | $6.15 | -30.73% |
| 2022-03-29 | 4 | $6 | $3.8 | $4.45 | $6.15 | -27.64% |
| 2022-05-13 | 3 | $60 | $30 | $45 | $6.15 | 631.71% |
| 2022-06-03 | 3 | $60 | $21 | $37 | $6.15 | 501.63% |
| 2022-09-26 | 3 | $35 | $12 | $22.666 | $6.15 | 268.55% |
| 2022-11-15 | 3 | $35 | $10 | $22 | $6.15 | 257.72% |
| 2022-11-16 | 3 | $35 | $10 | $18.333 | $6.15 | 198.1% |
| 2023-08-14 | 2 | $10 | $10 | $10 | $6.15 | 62.6% |
| 2023-11-15 | 1 | $12 | $12 | $12 | $6.15 | 95.12% |
Price Target Last Issued November 15, 2023
The Trend in the Analyst Price Target
CASI's average price target has moved up $7.55 over the prior 26 months.
Over the past 29 weeks, CASI's average upside potential has been 304.43%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-28 | 2 | 10 | 10 | 10 | 2.862 | 249.41% |
| 2023-05-22 | 2 | 10 | 10 | 10 | 2.050 | 387.8% |
| 2023-08-14 | 2 | 10 | 10 | 10 | 2.200 | 354.55% |
| 2023-08-14 | 1 | 10 | 10 | 10 | 2.200 | 354.55% |
| 2023-11-15 | 1 | 12 | 12 | 12 | 4.350 | 175.86% |
CASI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
CASI's average broker recommendation rating improved by 0.67 over the prior 30 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, CASI PHARMACEUTICALS INC's number of analysts covering the stock is higher than 111.78% of them.
- To contextualize these metrics, consider that out of all US stocks, CASI PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 721.27% of them.
- CASI has a higher average analyst price target than 230.37% of all US stocks.
- CASI PHARMACEUTICALS INC's variance in analysts' estimates is lower than -822.06% of stocks in the small market cap category.
In the Pharmaceutical Products industry, GERN, VERU, and LFVN are the three stocks most similar to CASI PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CASI using the data that counts. Try POWR Ratings for free.